Nuo Therapeutics raises $3.55M in private placement at $1.00/share with insider participation

Nuo Therapeutics, Inc.

Sold 3,550,000 shares of common stock at $1.00 per share for gross proceeds of $3,550,000.
Insider investors include CEO/CFO David Jorden ($10,532), director Scott Pittman ($100,000), COO Peter Clausen ($25,000), and principal holder Charles Sheedy ($804,868).
Proceeds to be used for working capital; post-offering shares outstanding increase to 40,674,205.
Shares issued under Section 4(a)(2) and Rule 506 in unregistered transaction; company not current in SEC reports.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.